InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ENANTA PHARMACEUTICALS INC

ENTA Clue Score19
United States Fiscal year ends September CIK 0001177648 Results filed 10 Aug 2026
Add to watchlist

What the insiders did No buying or selling

By person

9 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Jay R. Luly
President and CEO
—
—
—
871,871
$12.41M
+7.6%
Yat Sun Or
Chief Scientific Officer
—
—
—
374,854
$5.33M
+0.4%
Paul J Mellett
Chief Fin. & Admin Officer
—
—
—
95,884
$1.36M
0.0%
Brendan Luu
Chief Business Officer
—
—
—
41,634
$592.45K
+6.5%
Tara Lynn Kieffer
Chief Product Strategy Officer
—
—
—
33,925
$482.75K
+4.9%
Scott T. Rottinghaus
Chief Medical Officer
—
—
—
23,787
$338.49K
+26.6%
Harry R. Trout III
See Remarks
—
—
—
16,348
$232.63K
+49.8%
Kathleen S. Capps
See Remarks
—
—
—
8,377
$119.20K
+43.7%
Matthew Paul Kowalsky
Chief Legal Officer
—
—
—
3,591
$51.10K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.